HealthEquity, Inc. (HQY) News
Filter HQY News Items
HQY News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
HQY News Highlights
- For HQY, its 30 day story count is now at 21.
- Over the past 23 days, the trend for HQY's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
- The most mentioned tickers in articles about HQY are AMP, VIEW and NOTE.
Latest HQY News From Around the Web
Below are the latest news stories about HEALTHEQUITY INC that investors may wish to consider to help them evaluate HQY as an investment opportunity.
Here's Why You Should Retain Zimmer Biomet (ZBH) for NowInvestors are optimistic about Zimmer Biomet (ZBH) on business recovery and expansion in emerging markets. |
Here's Why You Should Invest in Penumbra (PEN) Stock for NowInvestors are optimistic about Penumbra (PEN), driven by growth in vascular and neuro businesses. |
Here's Why Investors Should Retain Omnicell (OMCL) Stock NowInvestors are optimistic about Omnicell (OMCL), led by its digital transformation strategy. |
Here's Why Investors Should Invest in Abbott (ABT) Stock NowInvestors are optimistic about Abbott (ABT) on strong growth in the Diagnostics business and upbeat guidance. |
QIAGEN (QGEN) Extends QIAwave Product Line With New KitQIAGEN's (QGEN) new QIAwave kits broaden its selection of environmentally friendly products and reaffirm its commitment to helping researchers advance science. |
HealthEquity (HQY) to Add Conduent's HSA Accounts in 2024HealthEquity (HQY) is set to receive the Conduent's HSA portfolio as a part of an agreement signed by the companies earlier this month. The deal is likely to boost HQY's business in 2024 and beyond. |
3 Reasons to Hold HealthEquity (HQY) Stock in Your PortfolioHealthEquity's (HQY) strength in HSA raises optimism about the stock. |
Abbott (ABT) Closes Acquisition Deal of Bigfoot BiomedicalAbbott's (ABT) footprint in the diabetes care market is increased by the Bigfoot Biomedical acquisition. |
Hologic (HOLX) to Boost Breast Imaging Modality With New PactHologic's (HOLX) collaboration with Bayer will enable physicians everywhere to include CEM in their breast cancer diagnosis workflows. |
3 Reasons to Hold Veeva Systems (VEEV) Stock in Your PortfolioVeeva Systems' (VEEV) strong product portfolio raises optimism about the stock. |